$0.9588
0.06987.85%
Last update: Nov 6, 5:44 PM
Radiopharm Theranostics Ltd (RADX) Stock Price, Quote, News & History
RADXNASDAQ
Wall Street analysts began coverage on top names, including a bullish rating on Radiopharm Theranostics. See more analyst ratings.
You can purchase shares of Radiopharm Theranostics (NASDAQ:RADX) through any online brokerage.
Other companies in Radiopharm Theranostics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Radiopharm Theranostics has a consensus price target of $15.50.
The stock price for Radiopharm Theranostics (NASDAQ: RADX) is $1.03 last updated November 6, 2026 at 5:44 PM EST.
There are no upcoming dividends for Radiopharm Theranostics.
Radiopharm Theranostics does not have any upcoming earnings scheduled.
There is no upcoming split for Radiopharm Theranostics.
Radiopharm Theranostics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Radiopharm Theranostics Ltd is a clinical-stage radiotherapeutics company focused on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. It develops and commercializes...
